Press, R. D., Eickelberg, G., Froman, A., Yang, F., Stentz, A., Flatley, E. M., . . . Cook, R. J. (2019). Next‐generation sequencing‐defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse. American journal of hematology, 94(8), 902-912. https://doi.org/10.1002/ajh.25514
Chicago-Zitierstil (17. Ausg.)Press, Richard D., et al. "Next‐generation Sequencing‐defined Minimal Residual Disease Before Stem Cell Transplantation Predicts Acute Myeloid Leukemia Relapse." American Journal of Hematology 94, no. 8 (2019): 902-912. https://doi.org/10.1002/ajh.25514.
MLA-Zitierstil (9. Ausg.)Press, Richard D., et al. "Next‐generation Sequencing‐defined Minimal Residual Disease Before Stem Cell Transplantation Predicts Acute Myeloid Leukemia Relapse." American Journal of Hematology, vol. 94, no. 8, 2019, pp. 902-912, https://doi.org/10.1002/ajh.25514.